Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
TECHNOLOGY
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
MARKETS
Strong On High Relative Volume: Enanta Pharmaceuticals (ENTA)
By TheStreet Wire
May 23, 2016 10:00 AM EDT
PRESS RELEASES
Brendan Luu, Senior Vice President, Business Development, Enanta Pharmaceuticals (Photo: Business Wire)
By Business Wire
Jan 26, 2021 7:00 AM EST
PRESS RELEASES
Enanta Pharmaceuticals To Provide Updates On Its Research And Development Programs And Outlook For 2021 At The 39th Annual J.P. Morgan Healthcare Conference
By Business Wire
Jan 8, 2021 7:01 AM EST
PRESS RELEASES
John P. DeVincenzo, M.D. (Photo: Business Wire)
By Business Wire
Jan 5, 2021 7:01 AM EST
PRESS RELEASES
Enanta Pharmaceuticals To Present At The 39th Annual J.P. Morgan Healthcare Conference
By Business Wire
Jan 5, 2021 6:00 AM EST
PRESS RELEASES
Enanta Pharmaceuticals To Present At Upcoming Investor Conferences
By Business Wire
Nov 18, 2020 7:02 AM EST
PRESS RELEASES
Enanta Pharmaceuticals To Host Conference Call On November 23 At 4:30 P.m. ET To Discuss Its Financial Results For Its Fiscal Fourth Quarter And Year Ended September 30, 2020
By Business Wire
Nov 16, 2020 7:02 AM EST
PRESS RELEASES
Enanta Pharmaceuticals To Present At The 4th Annual H.C. Wainwright Virtual NASH Investor Conference
By Business Wire
Sep 28, 2020 7:00 AM EDT
PRESS RELEASES
Enanta Pharmaceuticals Initiates Phase 1 Clinical Study Of EDP-297, Its Highly Potent And Targeted Follow-On Farnesoid X Receptor Agonist For The Treatment Of Non-Alcoholic Steatohepatitis
By Business Wire
Sep 14, 2020 7:00 AM EDT
PRESS RELEASES
Enanta Pharmaceuticals To Participate In Upcoming September Conferences
By Business Wire
Sep 3, 2020 7:01 AM EDT
PRESS RELEASES
Enanta Pharmaceuticals Announces Data Presentations At The European Association For The Study Of The Liver (EASL) Digital International Liver Congress™ 2020
By Business Wire
Aug 20, 2020 7:00 AM EDT
PRESS RELEASES
Enanta Pharmaceuticals To Present At The BTIG Virtual Biotechnology Conference 2020
By Business Wire
Aug 3, 2020 7:02 AM EDT
PRESS RELEASES
Enanta Pharmaceuticals To Host Conference Call On August 4 At 4:30 P.m. ET To Discuss Its Financial Results For Its Fiscal Third Quarter Ended June 30, 2020
By Business Wire
Jul 28, 2020 7:01 AM EDT
PRESS RELEASES
Enanta Pharmaceuticals Announces Clinical Trial Progress For EDP-514, Its Lead Core Inhibitor For Hepatitis B Virus
By Business Wire
Jul 9, 2020 7:01 AM EDT
PRESS RELEASES
Enanta Pharmaceuticals Announces The Appointment Of Mark G. Foletta To Its Board Of Directors (Photo: Business Wire)
By Business Wire
Jun 29, 2020 7:00 AM EDT
PRESS RELEASES
Enanta Pharmaceuticals To Present At The Raymond James Human Health Innovation Conference
By Business Wire
Jun 11, 2020 7:02 AM EDT
PRESS RELEASES
Enanta Pharmaceuticals To Present At The 2020 RBC Capital Markets Global Healthcare Virtual Conference
By Business Wire
May 12, 2020 7:30 AM EDT
PRESS RELEASES
Enanta Announces Results Of INTREPID Study Of EDP-305 For The Treatment Of Primary Biliary Cholangitis
By Business Wire
May 6, 2020 4:03 PM EDT
PRESS RELEASES
Enanta To Host Conference Call On May 6 At 4:30 P.m. ET To Discuss Financial Results For Its Fiscal Second Quarter Ended March 31, 2020
By Business Wire
Apr 28, 2020 4:05 PM EDT
PRESS RELEASES
Enanta Provides Update On Clinical Development Activities During COVID-19 Pandemic
By Business Wire
Mar 26, 2020 4:05 PM EDT
PRESS RELEASES
Enanta Pharmaceuticals Announces Efforts To Discover A Treatment For The Novel Coronavirus Disease COVID-19
By Business Wire
Mar 13, 2020 7:00 AM EDT
PRESS RELEASES
Enanta To Host Conference Call On February 6 At 4:30 P.m. ET To Discuss Financial Results For Its Fiscal First Quarter Ended December 31, 2019
By Business Wire
Jan 24, 2020 7:30 AM EST
PRESS RELEASES
Enanta To Provide Updates On Its R&D Programs And Business Outlook For 2020 During The 38th Annual J.P. Morgan Healthcare Conference
By Business Wire
Jan 9, 2020 7:30 AM EST
MARKETS
Strong On High Relative Volume: Enanta Pharmaceuticals (ENTA)
By TheStreet Wire
May 23, 2016 10:00 AM EDT
MARKETS
Insider Trading Alert - ENTA, EBIO And PSEC Traded By Insiders
By TheStreet Wire
Feb 18, 2016 10:00 AM EST
